Brief screening tools that detect and differentiate patients with amyotrophic lateral sclerosis and frontotemporal dementia (ALSFTD) from those more subtle cognitive or behavioral symptoms (ALS plus) and motor symptoms only (ALS pure) is pertinent in a clinical setting. The utility of 2 validated and data-driven tests (Mini-Addenbrooke’s Cognitive Examination [M-ACE] and Motor Neuron Disease Behavioral Scale [MiND-B]) was investigated in 70 ALS patients (24 ALSFTD, 19 ALS plus, and 27 ALS pure). More than 90% of patients with ALSFTD scored at or below the cutoff on the M-ACE, whereas this was seen in only about 20% of ALS patients without dementia. The MiND-B differentiated between ALS pure and ALS plus diagnostic categories. Rasch modeling of M-ACE and MiND-B items revealed early cognitive (fluency, memory recall) and behavioral (apathy) symptoms in ALSFTD. The combined use of the M-ACE and MiND-B detects patients with ALSFTD, differentiates along the ALS continuum, and offers insight into the progression of nonmotor symptomatology in ALSFTD.
NeumannMSampathuDMKwongLK. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133.
2.
BurrellJRKiernanMCVucicSHodgesJR. Motor neuron dysfunction in frontotemporal dementia. Brain. 2011;134(pt 9):2582-2594.
3.
AmbikairajahADevenneyEFlanaganE. A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3-4):226-234.
4.
GeserFLeeVMTrojanowskiJQ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology. 2010;30(2):103-112.
5.
LilloPSavageSMioshiEKiernanMCHodgesJR. Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotrophic Lateral Sclerosis. 2012;13(1):102-109.
6.
LilloPMioshiEBurrellJRKiernanMCHodgesJRHornbergerM. Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One. 2012;7(8):e43993.
7.
VanceCAl-ChalabiARuddyD. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain. 2006;129(pt 4):868-876.
8.
RentonAEMajounieEWaiteA. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257-268.
9.
RingholzGMAppelSHBradshawMCookeNAMosnikDMSchulzPE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65(4):586-590.
10.
GordonPHDelgadilloDPiquardA. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance. Amyotrophic Lateral Sclerosis. 2011;12(5):372-378.
11.
LilloPMioshiEZoingMCKiernanMCHodgesJR. How common are behavioural changes in amyotrophic lateral sclerosis?Amyotrophic Lateral Sclerosis. 2011;12(1):45-51.
12.
GoldsteinLHAbrahamsS. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368-380.
13.
WoolleySCYorkMKMooreDH. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotrophic Lateral Sclerosis. 2010;11(3):303-311.
14.
AbrahamsSNewtonJNivenEFoleyJBakTH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1-2):9-14.
15.
HsiehSMcGrorySLeslieF. The Mini-Addenbrooke’s cognitive examination: a new assessment tool for dementia. Dement Geriatr Cogn Disord. 2014;39(1-2):1-11.
16.
MioshiEHsiehSCagaJ. A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3-4):298-304.
17.
HsiehSMcGrorySLeslieF. The Mini-Addenbrooke’s cognitive examination: a new assessment tool for dementia. Dement Geriatr Cogn Disord. 2015;39(1-2):1-11.
18.
StrongMJGraceGMFreedmanM. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 2009;10(3):131-146.
19.
BrooksBRMillerRGSwashMMunsatTL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
20.
WeiQChenXZhengZHuangRGuoXCaoB. Screening for cognitive impairment in a Chinese ALS population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1-2):40-45.
21.
StraussEShermanEMSSpreenO. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. Oxford: Oxford University Press; 2006.
22.
HsiehSSchubertSHoonCMioshiEHodgesJR. Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36(3-4):242-250.
23.
MioshiEDawsonKMitchellJArnoldRHodgesJR. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21(11):1078-1085.
24.
AbrahamsSLeighPNHarveyAVythelingumGNGriséDGoldsteinLH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38(6):734-747.
25.
CedarbaumJMStamblerNMaltaE. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1-2):13-21.
26.
BondTGFoxCM. Applying the Rasch Model. Fundamental Measurement in the Human Sciences. Mahwah, NJ: Lawrence Erlbaum Associates; 2007.
27.
LinacreM. Rasch analysis and Winsteps; 2014. Web site. www.winteps.com/index.htm. WINSTEPS & Facets Rasch Software. (n.d.). Accessed August 21, 2014.
28.
MioshiECagaJLilloP. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology. 2014;82(2):149-155.
MantovanMCBaggioLDalla BarbaG. Memory deficits and retrieval processes in ALS. Eur J Neurol. 2003;10(3):221-227.
31.
HornbergerMPiguetO. Episodic memory in frontotemporal dementia: a critical review. Brain. 2012;135(pt 3):678-692.
32.
SavageSHsiehSLeslieFFoxeDPiguetOHodgesJR. Distinguishing subtypes in Primary Progressive Aphasia: application of the Sydney Language Battery. Dement Geriatr Cogn Disord. 2013;35(3-4):208-218.
33.
Gorno-TempiniMLHillisAEWeintraubS. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006-1014.
34.
MioshiELilloPYewB. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology. 2013;80(12):1117-1123.
35.
YewBAlladiSShailajaMHodgesJRHornbergerM. Lost and forgotten? Orientation versus memory in Alzheimer’s disease and frontotemporal dementia. J Alzheimers Dis. 2013;33(2):473-481.
ChareLHodgesJRLeytonCE. New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry. 2014;85(8):865-870.
38.
LilloPGarcinBHornbergerMBakTHHodgesJR. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010;67(7):826-830.
39.
CoonEASorensonEJWhitwellJLKnopmanDSJosephsKA. Predicting survival in frontotemporal dementia with motor neuron disease. Neurology. 2011;76(22):1886-1893.
40.
HodgesJRDaviesRXuerebJKrilJHallidayG. Survival in frontotemporal dementia. Neurology. 2003;61(3):349-354.
41.
ChioAVignolaAMastroE. Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of life. Eur J Neurol. 2010;17(10):1298-1303.
42.
LilloPMioshiEHodgesJR. Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients’ behavioural changes than physical disability: a comparative study. BMC Neurol. 2012;12:156.
43.
MartinNHLandauSJanssenA. Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5-6):376-387.
44.
OlneyRKMurphyJForshewD. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65(11):1774-1777.
45.
TaylorLJBrownRGTsermentseliS. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis?J Neurol Neurosurg Psychiatry. 2013;84(5):494-498.
46.
AshSMenagedAOlmC. Narrative discourse deficits in amyotrophic lateral sclerosis. Neurology. 2014;83(6):520-528.
